Certican 1,0 mg tabletes Latvija - latviešu - Zāļu valsts aģentūra

certican 1,0 mg tabletes

novartis baltics, sia, latvia - everolims - tablete - 1,0 mg

Certican 0,25 mg disperģējamās tabletes Latvija - latviešu - Zāļu valsts aģentūra

certican 0,25 mg disperģējamās tabletes

novartis baltics, sia, latvija - everolims - disperģējamā tablete - 0,25 mg

Certican 0,1 mg disperģējamās tabletes Latvija - latviešu - Zāļu valsts aģentūra

certican 0,1 mg disperģējamās tabletes

novartis baltics, sia, latvija - everolims - disperģējamā tablete - 0,1 mg

Certican 0,75 mg tabletes Latvija - latviešu - Zāļu valsts aģentūra

certican 0,75 mg tabletes

novartis baltics, sia, latvia - everolims - tablete - 0,75 mg

Hepcludex Eiropas Savienība - latviešu - EMA (European Medicines Agency)

hepcludex

gilead sciences ireland uc - bulevirtide acetate - hepatitis d, chronic - pretvīrusu līdzekļi sistēmiskai lietošanai - hepcludex is indicated for the treatment of chronic hepatitis delta virus (hdv) infection in plasma (or serum) hdv-rna positive adult patients with compensated liver disease.

Tabrecta Eiropas Savienība - latviešu - EMA (European Medicines Agency)

tabrecta

novartis europharm limited  - capmatinib dihydrochloride monohydrate - karcinoma, nesīkšūnu plaušas - antineoplastiski līdzekļi - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.

Teriflunomide Mylan Eiropas Savienība - latviešu - EMA (European Medicines Agency)

teriflunomide mylan

mylan pharmaceuticals limited - teriflunomīds - multiplā skleroze, recidivējoši-pārskaitot - imūnsupresanti - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Teriflunomide Accord Eiropas Savienība - latviešu - EMA (European Medicines Agency)

teriflunomide accord

accord healthcare s.l.u. - teriflunomīds - multiplā skleroze, recidivējoši-pārskaitot - immunosuppressants, selektīvi immunosuppressants - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Bozilos 14 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

bozilos 14 mg apvalkotās tabletes

egis pharmaceuticals plc, hungary - teriflunomīds - apvalkotā tablete - 14 mg

Terebyo 14 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

terebyo 14 mg apvalkotās tabletes

sandoz d.d., slovenia - teriflunomīds - apvalkotā tablete - 14 mg